Literature DB >> 25130171

Hypoxia inducible factor (HIF)-1α directly activates leptin receptor (Ob-R) in pancreatic cancer cells.

He Ren1, Lingling Jia2, Tiansuo Zhao1, Huan Zhang1, Jing Chen1, Shaoguang Yang1, Jingcheng Liu1, Ming Yu2, Jihui Hao3.   

Abstract

The aim of this study is to investigate the regulatory mechanism of leptin receptors (Ob-R) in pancreatic cancer. We found that the over-expression of hypoxia inducible factor (HIF-1)α and hypoxia up-regulated the expression of Ob-R in pancreatic cancer cells. When HIF-1α gene was silenced in vitro, the expression of Ob-R was significantly decreased. Xenograft mouse models showed that the inhibition of HIF-1α resulted in the concomitant decrease of Ob-R in vivo. In addition, HIF-1α expression was correlated with Ob-R in pancreatic cancer tissues by immunohistochemical staining. Clinical data showed that over-expression of HIF-1 was associated with pathological tumor node metastasis stage, lymph node metastasis and overall survival. HIF-1α directly bound to the hypoxia-responsive element (HRE) located in Ob-R gene promoter (-828/-832) and activated the transcription. Finally, we demonstrated that the silence of HIF-1α gene reversed the inhibitory effect of leptin/Ob-R in pancreatic cancer cells. Taken together, our results indicate that HIF-1α directly regulated Ob-R expression in pancreatic cancer, which might be a valuable therapeutic target for pancreatic cancer.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Hypoxia inducible factor-1α (HIF-1α); Leptin; Leptin receptor (Ob-R); Pancreatic cancer

Mesh:

Substances:

Year:  2014        PMID: 25130171     DOI: 10.1016/j.canlet.2014.08.001

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  22 in total

1.  HIF-1 is a critical target of pancreatic cancer.

Authors:  Jihui Hao
Journal:  Oncoimmunology       Date:  2015-07-17       Impact factor: 8.110

Review 2.  New targeted therapies in pancreatic cancer.

Authors:  Andrada Seicean; Livia Petrusel; Radu Seicean
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

3.  LOX and ACSL5 as potential relapse markers for pancreatic cancer patients.

Authors:  Weidong Ma; Ting Li; Si Wu; Jian Li; Xiuchao Wang; Hui Li
Journal:  Cancer Biol Ther       Date:  2019-02-03       Impact factor: 4.742

Review 4.  Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer.

Authors:  Simone Polvani; Mirko Tarocchi; Sara Tempesti; Lapo Bencini; Andrea Galli
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

Review 5.  The potential role of leptin in tumor invasion and metastasis.

Authors:  Amitabha Ray; Margot P Cleary
Journal:  Cytokine Growth Factor Rev       Date:  2017-11-11       Impact factor: 7.638

6.  PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis.

Authors:  Cheng Zhang; Wei Tian; Lin Meng; Like Qu; Chengchao Shou
Journal:  J Mol Med (Berl)       Date:  2015-11-09       Impact factor: 4.599

7.  Leptin signaling enhances cell invasion and promotes the metastasis of human pancreatic cancer via increasing MMP-13 production.

Authors:  Yingchao Fan; Yu Gan; Yuling Shen; Xiaojin Cai; Yanfang Song; Fangyu Zhao; Ming Yao; Jianren Gu; Hong Tu
Journal:  Oncotarget       Date:  2015-06-30

8.  Single nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomes.

Authors:  Xiuchao Wang; He Ren; Tiansuo Zhao; Weidong Ma; Jie Dong; Shengjie Zhang; Wen Xin; Shengyu Yang; Li Jia; Jihui Hao
Journal:  Oncotarget       Date:  2016-03-22

Review 9.  Influential Factors and Synergies for Radiation-Gene Therapy on Cancer.

Authors:  Mei Lin; Junxing Huang; Yujuan Shi; Yanhong Xiao; Ting Guo
Journal:  Anal Cell Pathol (Amst)       Date:  2015-12-09       Impact factor: 2.916

Review 10.  Cancer as a Proinflammatory Environment: Metastasis and Cachexia.

Authors:  Nelson Inácio Pinto; June Carnier; Lila M Oyama; Jose Pinhata Otoch; Paulo Sergio Alcântara; Flavio Tokeshi; Claudia M Nascimento
Journal:  Mediators Inflamm       Date:  2015-10-05       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.